Yufeng Shi
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Topics
- Cancer, Hypoxia, and Metabolism (7 papers)Mitochondrial Function and Pathology (5 papers)Epigenetics and DNA Methylation (5 papers)
- Journals
- NatureProceedings of the National Academy of SciencesSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yufeng Shi
32 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 801
- Cancer Research 393
- Immunology 236
- Oncology 222
- Pulmonary and Respiratory Medicine 158
Countries citing papers authored by Yufeng Shi
This map shows the geographic impact of Yufeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Shi more than expected).
Fields of papers citing papers by Yufeng Shi
This network shows the impact of papers produced by Yufeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Shi. The network helps show where Yufeng Shi may publish in the future.
Co-authorship network of co-authors of Yufeng Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Shi. A scholar is included among the top collaborators of Yufeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Shi. Yufeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancerbreakdown → | 91 |
| 3 | 4 | |
| 4 | 13 | |
| 5 | Emerging phagocytosis checkpoints in cancer immunotherapybreakdown → | 166 |
| 6 | 16 | |
| 7 | 25 | |
| 8 | 14 | |
| 9 | 37 | |
| 10 | An Overview: The Diversified Role of Mitochondria in Cancer Metabolismbreakdown → | 137 |
| 11 | 13 | |
| 12 | 93 | |
| 13 | 19 | |
| 14 | 53 | |
| 15 | 45 | |
| 16 | 34 | |
| 17 | 23 | |
| 18 | 11 | |
| 19 | 38 | |
| 20 | 23 |
About Yufeng Shi
Yufeng Shi is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (393 citations), Genetics (124 citations) and Molecular Biology (801 citations). Yufeng Shi has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yue Liu, Jin Zhang, Daochun Sun, Zilai Wang, Yu-Jung Chen, Lan Fang, Viviane Tabar, Xuanhua Xie, Luis F. Parada and Linjun Weng. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.